Stock Screener
Stock Research
Top Dividend Stocks
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Economy

Prothena Revenue 2011-2018 | PRTA

Prothena annual/quarterly revenue history and growth rate from 2011 to 2018. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Prothena revenue for the quarter ending June 30, 2018 was $0.000B, a 98.96% decline year-over-year.
  • Prothena revenue for the twelve months ending June 30, 2018 was $0.001B, a 96.53% decline year-over-year.
  • Prothena annual revenue for 2017 was $0.028B, a 2508.44% increase from 2016.
  • Prothena annual revenue for 2016 was $0.001B, a 34.35% decline from 2015.
  • Prothena annual revenue for 2015 was $0.002B, a 96.84% decline from 2014.
Prothena Annual Revenue
(Millions of US $)
2017 $28
2016 $1
2015 $2
2014 $51
2013 $1
2012 $3
2011 $1
2010 $1
Prothena Quarterly Revenue
(Millions of US $)
Q2 2018 $0
Q1 2018 $0
Q4 2017 $0
Q3 2017 $0
Q2 2017 $27
Q1 2017 $0
Q4 2016 $0
Q3 2016 $0
Q2 2016 $0
Q1 2016 $0
Q4 2015 $0
Q3 2015 $0
Q2 2015 $0
Q1 2015 $1
Q4 2014 $2
Q3 2014 $1
Q2 2014 $15
Q1 2014 $32
Q4 2013 $0
Q3 2013 $0
Q2 2013 $0
Q1 2013 $0
Q4 2012 $1
Q3 2012 $1
Q2 2012 $1
Q1 2012 $0
Q4 2011 $0
Q4 2010 $0
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.517B $0.028B
Prothena Corporation plc is a biotechnology company focused on the discovery and development of therapeutic monoclonal antibodies for disease-causing proteins. The Company is developing the following programs: NEOD001 for Amyloidosis, NEOD002 for Parkinson's disease, MCAM for Inflammatory disease and Metastatic Cancer and Tau for Alzheimer's disease. Prothena Corporation plc is headquartered in Dublin, Ireland.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $130.619B 14.99
Gilead Sciences (GILD) United States $94.983B 10.54
Biogen (BIIB) United States $64.544B 13.68
Celgene (CELG) United States $57.964B 11.57
Illumina (ILMN) United States $46.026B 57.66
Vertex Pharmaceuticals (VRTX) United States $44.899B 102.15
Regeneron Pharmaceuticals (REGN) United States $42.123B 23.68
Alexion Pharmaceuticals (ALXN) United States $28.056B 21.09
BioMarin Pharmaceutical (BMRN) United States $18.331B 0.00
Incyte (INCY) United States $14.043B 471.86
Seattle Genetics (SGEN) United States $11.401B 0.00
Sarepta Therapeutics (SRPT) United States $8.918B 0.00
QIAGEN (QGEN) Netherlands $8.196B 26.80
Alnylam Pharmaceuticals (ALNY) United States $7.716B 0.00
Exact Sciences (EXAS) United States $7.567B 0.00
BeiGene (BGNE) Cayman Islands $6.707B 0.00
Bio-Techne Corp (TECH) United States $6.702B 44.82
Bluebird Bio (BLUE) United States $6.537B 0.00
Alkermes (ALKS) Ireland $6.237B 0.00
Amarin (AMRN) Ireland $5.762B 0.00
Galapagos (GLPG) Belgium $5.520B 0.00
Exelixis (EXEL) United States $4.849B 15.80
Immunomedics (IMMU) United States $4.475B 0.00
Ligand Pharmaceuticals (LGND) United States $3.957B 35.05
Myriad Genetics (MYGN) United States $3.307B 35.13
Array BioPharma (ARRY) United States $3.226B 0.00
Horizon Pharma Public (HZNP) Ireland $3.178B 17.99
Ultragenyx Pharmaceutical (RARE) United States $3.176B 0.00
Emergent Biosolutions (EBS) United States $3.038B 24.20
MorphoSys AG Unsponsored ADR (MOR) Germany $3.034B 0.00
GUARDANT HEALTH (GH) United States $2.991B 0.00
Blueprint Medicines (BPMC) United States $2.981B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.830B 0.00
Ascendis Pharma (ASND) Denmark $2.798B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.776B 0.00
ARGENX SE-ADR (ARGX) Netherlands $2.619B 0.00
Repligen (RGEN) United States $2.416B 81.10
Halozyme Therapeutics (HALO) United States $2.361B 31.46
Acceleron Pharma (XLRN) United States $2.360B 0.00
China Biologic Products (CBPO) China $2.352B 16.17
Genomic Health (GHDX) United States $2.309B 128.80
Amicus Therapeutics (FOLD) United States $2.264B 0.00
MyoKardia (MYOK) United States $2.223B 0.00
Akcea Therapeutics (AKCA) United States $2.019B 0.00
Medicines (MDCO) United States $1.985B 0.00
Arena Pharmaceuticals (ARNA) United States $1.974B 0.00
Global Blood Therapeutics (GBT) United States $1.968B 0.00
AnaptysBio (ANAB) United States $1.893B 0.00
REGENXBIO (RGNX) United States $1.886B 29.63
Cambrex (CBM) United States $1.877B 15.05
Allakos (ALLK) United States $1.815B 0.00
Reata Pharmaceuticals (RETA) United States $1.804B 0.00
Spark Therapeutics (ONCE) United States $1.794B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.768B 0.00
CRISPR THERAPTC (CRSP) Switzerland $1.701B 0.00
Puma Biotechnology (PBYI) United States $1.604B 0.00
Innoviva (INVA) United States $1.597B 10.25
Aimmune Therapeutics (AIMT) United States $1.596B 0.00
Atara Biotherapeutics (ATRA) United States $1.586B 0.00
Denali Therapeutics (DNLI) United States $1.582B 0.00
G1 THERAPEUTICS (GTHX) United States $1.564B 0.00
Myovant Sciences (MYOV) United Kingdom $1.433B 0.00
Sangamo Therapeutics (SGMO) United States $1.412B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $1.404B 0.00
WAVE Life Sciences (WVE) Singapore $1.395B 0.00
Clovis Oncology (CLVS) United States $1.388B 0.00
Rubius Therapeutics (RUBY) United States $1.354B 0.00
Editas Medicine (EDIT) United States $1.311B 0.00
Mirati Therapeutics (MRTX) United States $1.295B 0.00
IMMURON LTD (IMRN) Australia $1.287B 0.00
Insmed (INSM) United States $1.264B 0.00
Solid Biosciences (SLDB) United States $1.224B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.212B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.152B 2200.00
NeoGenomics (NEO) United States $1.123B 196.43
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.102B 0.00
Cellectis (CLLS) France $1.090B 0.00
DBV Technologies (DBVT) France $1.079B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.069B 0.00
Retrophin (RTRX) United States $1.033B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.016B 0.00
Audentes Therapeutics (BOLD) United States $1.007B 0.00
Intra-Cellular Therapies (ITCI) United States $0.996B 0.00
UniQure (QURE) Netherlands $0.994B 0.00
Intellia Therapeutics (NTLA) United States $0.962B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $0.951B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.951B 0.00
Lion Biotechnologies (IOVA) United States $0.945B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.921B 0.00
Revance Therapeutics (RVNC) United States $0.885B 0.00
Aptinyx (APTX) United States $0.874B 0.00
Athenex (ATNX) United States $0.862B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.859B 0.00
Acorda Therapeutics (ACOR) United States $0.848B 17.68
Viking Therapeutics (VKTX) United States $0.839B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.838B 0.00
Coherus BioSciences (CHRS) United States $0.836B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.787B 0.00
InflaRx (IFRX) Germany $0.777B 0.00
Cara Therapeutics (CARA) United States $0.773B 0.00
Fate Therapeutics (FATE) United States $0.755B 0.00
Apellis Pharmaceuticals (APLS) United States $0.755B 0.00
Heska (HSKA) United States $0.752B 64.70
Inotek Pharmaceuticals (RCKT) United States $0.745B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.742B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.727B 0.00
Novavax (NVAX) United States $0.723B 0.00
Epizyme (EPZM) United States $0.693B 0.00
CytomX Therapeutics (CTMX) United States $0.692B 0.00
Dynavax Technologies (DVAX) United States $0.682B 0.00
AVROBIO (AVRO) United States $0.657B 0.00
ANI Pharmaceuticals (ANIP) United States $0.650B 12.88
NuCana Sponsored ADR (NCNA) United Kingdom $0.646B 0.00
Mesoblast (MESO) Australia $0.642B 0.00
AC Immune SA (ACIU) Switzerland $0.635B 0.00
ObsEva SA (OBSV) Switzerland $0.600B 0.00
Anika Therapeutics (ANIK) United States $0.598B 25.15
MiMedx (MDXG) United States $0.590B 25.29
UROGEN PHARMA (URGN) Israel $0.577B 0.00
Kura Oncology (KURA) United States $0.546B 0.00
Principia Biopharma (PRNB) United States $0.539B 0.00
RA PHARMCTL INC (RARX) United States $0.538B 0.00
Scholar Rock Holding (SRRK) United States $0.527B 0.00
Arcus Biosciences (RCUS) United States $0.524B 0.00
Five Prime Therapeutics (FPRX) United States $0.509B 0.00
ARVINAS INC (ARVN) United States $0.500B 0.00
Inovio Pharmaceuticals (INO) United States $0.498B 0.00
Aduro Biotech (ADRO) United States $0.497B 0.00
Kezar Life Sciences (KZR) United States $0.487B 0.00
Vericel (VCEL) United States $0.484B 0.00
Stemline Therapeutics (STML) United States $0.484B 0.00
UNITY Biotechnology (UBX) $0.478B 0.00
Senesco Technologies (ELOX) United States $0.459B 0.00
Abeona Therapeutics (ABEO) United States $0.448B 0.00
BeyondSpring (BYSI) United States $0.446B 0.00
Kindred Biosciences (KIN) United States $0.435B 0.00
GRITSTONE ONCLG (GRTS) United States $0.433B 0.00
MediciNova (MNOV) United States $0.432B 0.00
Sinovac Biotech (SVA) China $0.428B 0.00
Verastem (VSTM) United States $0.419B 0.00
Liquidia Technologies (LQDA) United States $0.416B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.410B 0.00
Zymeworks (ZYME) Canada $0.407B 0.00
Zealand Pharma (ZEAL) Denmark $0.400B 0.00
Cytokineticsorporated (CYTK) United States $0.397B 0.00
Sorrento Therapeutics (SRNE) United States $0.395B 67.60
Keryx Biopharmaceuticals (KERX) United States $0.387B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.381B 0.00
UROVANT SCIENCS (UROV) United States $0.381B 0.00
PDL BioPharma (PDLI) United States $0.369B 5.18
Merus (MRUS) Netherlands $0.367B 0.00
Replimune (REPL) United States $0.366B 0.00
Osiris Therapeutics (OSIR) United States $0.362B 0.00
MeiraGTx Holdings (MGTX) United States $0.360B 0.00
KODIAK SCIENCES (KOD) United States $0.355B 0.00
Eidos Therapeutics (EIDX) United States $0.350B 0.00
ResTORbio (TORC) United States $0.334B 0.00
Magenta Therapeutics (MGTA) United States $0.332B 0.00
SUTRO BIOPHARMA (STRO) United States $0.332B 0.00
Albireo Pharma (ALBO) United States $0.331B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.320B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.316B 0.00
Selecta Biosciences (SELB) United States $0.309B 0.00
Kala Pharmaceuticals (KALA) United States $0.307B 0.00
Geron (GERN) United States $0.307B 0.00
Evelo Biosciences (EVLO) United States $0.305B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.304B 0.00
MannKind (MNKD) United States $0.304B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.296B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.296B 0.00
Kadmon Holdings (KDMN) United States $0.295B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.292B 0.00
Proteostasis Therapeutics (PTI) United States $0.292B 0.00
Unum Therapeutics (UMRX) United States $0.288B 0.00
Celcuity (CELC) United States $0.287B 0.00
Adverum Biotechnologies (ADVM) United States $0.282B 0.00
Athersys (ATHX) United States $0.281B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.281B 0.00
Cellular Biomedicine (CBMG) United States $0.279B 0.00
Seres Therapeutics (MCRB) United States $0.266B 0.00
Axovant Sciences (AXON) United Kingdom $0.264B 0.00
BioTime (BTX) United States $0.258B 0.00
ADMA Biologics Inc (ADMA) United States $0.256B 0.00
Krystal Biotech (KRYS) United States $0.249B 0.00
Celyad SA (CYAD) Belgium $0.249B 0.00
Arbutus Biopharma (ABUS) Canada $0.240B 0.00
Syros Pharmaceuticals (SYRS) United States $0.239B 0.00
Kamada (KMDA) Israel $0.237B 18.41
TOCAGEN INC (TOCA) United States $0.236B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.234B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.234B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.233B 0.00
Synlogic (SYBX) United States $0.230B 0.00
Strongbridge Biopharma (SBBP) United States $0.227B 0.00
Agenus (AGEN) United States $0.222B 0.00
BioDelivery Sciences (BDSI) United States $0.217B 0.00
NantKwest (NK) United States $0.215B 0.00
Allena Pharmaceuticals (ALNA) United States $0.214B 0.00
Protagonist Therapeutics (PTGX) United States $0.208B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.205B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.202B 0.00
ChromaDex (CDXC) United States $0.201B 0.00
Idera Pharmaceuticals (IDRA) United States $0.191B 0.00
Compugen (CGEN) Israel $0.187B 0.00
Mersana Therapeutics (MRSN) United States $0.186B 0.00
Cerecor (CERC) United States $0.184B 18.83
Constellation Pharmaceuticals (CNST) United States $0.182B 0.00
Palatin Technologies (PTN) United States $0.181B 7.45
Cohbar (CWBR) United States $0.178B 0.00
Clearside Biomedical (CLSD) United States $0.175B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.174B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.170B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.169B 0.00
Intec Pharma (NTEC) Israel $0.168B 0.00
Spero Therapeutics (SPRO) United States $0.155B 0.00
Enzo Biochem (ENZ) United States $0.155B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.154B 0.00
OVID THERAPEUTC (OVID) United States $0.152B 0.00
Signal Genetics (MGEN) United States $0.145B 0.00
PSivida (EYPT) United States $0.143B 0.00
Pfenex (PFNX) United States $0.141B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.140B 0.00
Pluristem Therapeutics (PSTI) Israel $0.136B 0.00
Cue Biopharma (CUE) United States $0.136B 0.00
Mustang Bio (MBIO) United States $0.136B 0.00
Monster Digital (INNT) United States $0.131B 0.00
Menlo Therapeutics (MNLO) United States $0.130B 0.00
VTv Therapeutics (VTVT) United States $0.129B 0.00
XBiotech (XBIT) United States $0.127B 0.00
VBI Vaccines (VBIV) United States $0.126B 0.00
XOMA (XOMA) United States $0.126B 13.27
Anavex Life Sciences (AVXL) United States $0.125B 0.00
Eleven Biotherapeutics (SESN) United States $0.125B 0.00
Organovo Holdings (ONVO) United States $0.124B 0.00
Motif Bio Plc (MTFB) United States $0.123B 0.00
CorMedix Inc (CRMD) United States $0.122B 0.00
Applied Genetic Technologies (AGTC) United States $0.117B 0.00
Provention Bio (PRVB) United States $0.114B 0.00
Catalyst Biosciences (CBIO) United States $0.113B 0.00
ITUS (ANIX) United States $0.113B 0.00
Axsome Therapeutics (AXSM) United States $0.109B 0.00
Cidara Therapeutics (CDTX) United States $0.108B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.101B 0.00
BioXcel Therapeutics (BTAI) United States $0.098B 0.00
VolitionRX (VNRX) Singapore $0.098B 0.00
Neothetics (EVFM) United States $0.098B 0.00
Orgenesis (ORGS) United States $0.097B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.097B 0.00
Cel-Sci (CVM) United States $0.096B 0.00
Leap Therapeutics (LPTX) United States $0.096B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.095B 0.00
Aptevo Therapeutics (APVO) United States $0.091B 0.00
Chiasma (CHMA) United States $0.091B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.089B 0.00
Checkpoint Therapeutics (CKPT) United States $0.089B 0.00
Prima BioMed (IMMP) Australia $0.088B 0.00
OncoSec Medical (ONCS) United States $0.084B 0.00
Cocrystal Pharma (COCP) United States $0.084B 0.00
ScPharmaceuticals (SCPH) United States $0.082B 0.00
Ophthotech (OPHT) United States $0.082B 0.53
Protalix BioTherapeutics (PLX) Israel $0.081B 0.00
NewLink Genetics (NLNK) United States $0.080B 0.00
Vaccinex (VCNX) United States $0.080B 0.00
Aptose Biosciences (APTO) Canada $0.076B 0.00
Alcobra (ARCT) United States $0.072B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.071B 0.00
Sophiris Bio (SPHS) United States $0.071B 0.00
BIONANO GENOMIC (BNGO) United States $0.070B 0.00
Evogene (EVGN) Israel $0.069B 0.00
Curis (CRIS) United States $0.068B 0.00
Celldex Therapeutics (CLDX) United States $0.067B 0.00
Alimera Sciences (ALIM) United States $0.067B 0.00
Entera Bio (ENTX) Israel $0.065B 0.00
Oncobiologics (ONS) United States $0.064B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.064B 0.00
Trevena (TRVN) United States $0.063B 0.00
VistaGen Therapeutics (VTGN) United States $0.057B 0.00
Bellerophon Therapeutics (BLPH) United States $0.055B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.054B 0.00
Oncolytics Biotech (ONCY) Canada $0.053B 0.00
Fortress Biotech (FBIO) United States $0.052B 0.00
Vascular Biogenics (VBLT) Israel $0.052B 0.00
Asterias Biotherapeutics (AST) United States $0.050B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.050B 0.00
Zosano Pharma (ZSAN) United States $0.049B 0.00
TRACON Pharmaceuticals (TCON) United States $0.045B 0.00
AZURRX BIOPHARM (AZRX) United States $0.045B 0.00
Celsion (CLSN) United States $0.045B 0.00
Caladrius Biosciences (CLBS) United States $0.044B 0.00
VIVUS (VVUS) United States $0.044B 0.00
GTx (GTXI) United States $0.043B 0.00
AquaBounty Technologies (AQB) United States $0.043B 0.00
Eyenovia (EYEN) United States $0.038B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.036B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.035B 0.00
Proteon Therapeutics (PRTO) United States $0.035B 0.00
Aileron Therapeutics (ALRN) United States $0.035B 0.00
BioPharmX (BPMX) United States $0.035B 0.00
Advaxis (ADXS) United States $0.034B 0.00
Moleculin Biotech (MBRX) United States $0.033B 0.00
Galena Biopharma (SLS) United States $0.031B 0.00
OvaScience (OVAS) United States $0.029B 0.00
Cellect Biotechnology (APOP) Israel $0.028B 0.00
CytRx (CYTR) United States $0.028B 0.00
Benitec Biopharma (BNTC) Australia $0.027B 0.00
Vical (VICL) United States $0.027B 0.00
GENPREX INC (GNPX) United States $0.027B 0.00
Edge Therapeutics (EDGE) United States $0.025B 0.00
AEterna Zentaris (AEZS) United States $0.024B 48.67
Akari Therapeutics (AKTX) United Kingdom $0.023B 0.00
Arsanis (ASNS) United States $0.021B 0.00
Histogenics (HSGX) United States $0.021B 0.00
Soligenix (SNGX) United States $0.021B 0.00
ATyr Pharma (LIFE) United States $0.021B 0.00
Gemphire Therapeutics (GEMP) United States $0.020B 0.00
TrovaGene (TROV) United States $0.019B 0.00
Novelion Therapeutics (NVLN) Canada $0.019B 0.00
RestorGenex (DFFN) United States $0.019B 0.00
Cleveland BioLabs (CBLI) United States $0.019B 0.00
Genetic Technologies (GENE) Australia $0.019B 0.00
Fibrocell Science Inc (FCSC) United States $0.018B 0.00
Prana Biotechnology (PRAN) Australia $0.018B 0.00
Adial Pharmaceuticals (ADIL) United States $0.017B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.017B 0.00
Pulmatrix (PULM) United States $0.016B 0.00
Therapix Biosciences (TRPX) Israel $0.015B 5.58
IBio (IBIO) United States $0.015B 0.00
Novogen (KZIA) Australia $0.014B 0.00
Oragenics (OGEN) United States $0.014B 0.00
Vital Therapies (VTL) United States $0.013B 0.00
Neuralstem (CUR) United States $0.013B 0.00
Cerulean Pharma (DARE) United States $0.011B 0.00
Flex Pharma (FLKS) United States $0.011B 0.00
Alliqua BioMedical (ALQA) United States $0.010B 0.00
Hemispherx BioPharma (HEB) United States $0.010B 0.00
ARCA Biopharma (ABIO) United States $0.009B 0.00
MYOS RENS Technology (MYOS) United States $0.008B 0.00
Titan Pharmaceuticals (TTNP) United States $0.008B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.008B 0.00
Tenax Therapeutics (TENX) United States $0.007B 0.00
Synthetic Biologics (SYN) United States $0.007B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
AmpliPhi Biosciences (APHB) United States $0.005B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.003B 0.00
Aytu Bioscience (AYTU) United States $0.002B 0.00
Bio-Rad Laboratories (BIO.B) United States $0.000B 0.00
Y-MABS THERAPTC (YMAB) United States $0.000B 0.00